Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-Week Randomized, Double-Blind, Multicenter, Mechanistic Study With a 24-Week Open-Label Follow-Up to Evaluate the Effect of Avandia on Bone in Postmenopausal Women With Type 2 Diabetes Mellitus

Trial Profile

A 52-Week Randomized, Double-Blind, Multicenter, Mechanistic Study With a 24-Week Open-Label Follow-Up to Evaluate the Effect of Avandia on Bone in Postmenopausal Women With Type 2 Diabetes Mellitus

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rosiglitazone (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline

Most Recent Events

  • 16 Oct 2012 Results assessing the effects of treatment on osteoclast activity presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
  • 24 Mar 2012 Substudy assessing muscle mass and adiposity presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
  • 20 Sep 2011 Results assessing the effects of treatment on adiposity and muscle mass presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top